Form D — OptoVista Holdings, LLC
0002036372-26-000003 · filed Sep 25, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $3,727,518
- Total sold
- $3,727,518
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OptoVista Holdings, LLC
- CIK
- 2036372
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- C/O Tern Therapeutics, 1200 G STREET, NW
WASHINGTON, DC 20005 - Phone
- 703-919-6983
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matthew Michael Rosini · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Alexander Bailey · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Christina Ohnsman · Executive OfficerWashington, DC Find on LinkedIn ↗
-
Steven Oliveira · DirectorWashington, DC Find on LinkedIn ↗
-
Kerry Propper · DirectorWashington, DC Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗